Skip to main content

Contrast-enhanced dynamic and diffusion-weighted magnetic resonance imaging at 3.0 T to assess early-stage nasopharyngeal carcinoma

Buy Article:

$42.00 + tax (Refund Policy)

The present study aimed to assess early-stage nasopharyngeal carcinoma (NPC) with dynamic contrast-enhanced magnetic resonance imaging (DCEMRI) and diffusionweighted imaging (DWI) at 3.0 T. A total of 44 patients newly diagnosed with NPC were included in the present study. All patients underwent MR examination at 3.0 T using DCEMRI and DWI. The volume transfer constant (Ktrans), flux rate constant between extravascular extracellular space and plasma (Kep), the volume of extravascular extracellular space per unit volume of tissue (Ve) and the apparent diffusion coefficient (ADC) of tumours were investigated. Furthermore, the correlation between clinical stages and ADC value and Ktrans were analysed. The diagnostic accuracy of Ktrans and ADC were estimated using receiver operating characteristic curves. NPC stage correlated positively with Ktrans and negatively with ADC values. Additionally, tumour Ktrans negatively correlated with ADC value. The sensitivity and accuracy of combined Ktrans and ADC in distinguishing between stage II and stage III and stage III and IV were higher than the values of either measurement used separately. The present study suggested that Ktrans and ADC derived from DCEMRI and DWI may be useful to detect stage early NPC accurately. Ktrans and ADC in combination were superior than either alone.

Document Type: Research Article

Affiliations: Department of Radiology, Anhui Medical University Affiliated Anhui Provincial Hospital, Hefei, Anhui 230001, P.R. China

Publication date: 01 April 2018

More about this publication?
  • Oncology Letters is a monthly, peer-reviewed journal, available in print and online, that focuses on all aspects of clinical oncology, as well as in vitro and in vivo experimental model systems relevant to the mechanisms of disease.

    The principal aim of Oncology Letters is to provide the prompt publication of original studies of high quality that pertain to clinical oncology, chemotherapy, oncogenes, carcinogenesis, metastasis, epidemiology and viral oncology in the form of original research, reviews and case reports.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content